| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| |
| | | UNI - EN REPORT No | 129 | / | 2013 |
| | |
| | Date of issue: | 2013-10-09 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Sopharma monthly September 2013 | |
| | Official market - legal basis | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
| |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | Sopharma AD (the “Company") notifies that for September 2013 the Company realized an increase of sales revenues of 12% compared to the same period of 2012, including 17% increase of domestic sales and 10% increase of export sales.
During the past nine months Sopharma AD recorded a decrease of sales revenues of 1%, including 6% increase of domestic sales and 3% decrease of export sales compared to the same period of 2012.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | Sopharma monthly September 2013.doc
| Sopharma monthly September 2013 | |
